Note 12 STOCK-BASED COMPENSATION
 
Restricted Stock Awards and Restricted Stock Units
 
The table below includes issuances of restricted stock awards and units under the 2020 Plan and unvested equity interests of MOR which were converted into restricted common stock.
 
     Number of
Restricted Shares
and Units
     Weighted Average
Grant Date Fair
Value Per Share
 
Unvested at January 1, 2024   744,985   $2.05 
Issued   1,176,000    2.22 
Vested   (268,737   4.78 
Canceled   (5,000   9.47 
Unvested at December 31, 2024   1,647,248    3.03 
Issued   1,050,000    2.02 
Vested   (388,750   3.92 
Canceled   (567,250   2.33 
Unvested at December 31, 2025   1,741,248   $2.31 
 
The 1,741,248 of unvested awards at December 31, 2025 consisted of restricted stock units.
Stock Options
 
The fair value of the stock options was estimated using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgement. The assumptions used to calculate the grant date fair value of the options granted during the years ended December 31, 2025 and 2024, are as follows:
 
     
     
       
  For the Years Ended December 31,
    2025   2024
Exercise Price   $1.90 to $2.24   $2.02 to $3.69
Fair value of Company common stock   $1.90 to $2.24   $2.02 to $3.69
Dividend yield  0%  0%
Expected volatility   69% to 75%   74% to 79%
Risk Free interest rate   3.80% to 4.20%   3.80% to 4.20%
Expected life (years) remaining   6.10 to 6.25   6.10 to 6.25
 
The following summarizes option activity under the Company’s stock plan for the years ended December 31, 2025 and 2024:
 
         
         
     Shares Underlying
Options
     Weighted Average
Exercise Price
 
Outstanding at January 1, 2024   3,840,544   $7.12 
Granted   483,500   $2.79 
Exercised   (14,375  $2.98 
Forfeited and expired   (357,873  $7.49 
Outstanding at December 31, 2024   3,951,796   $6.47 
Granted   208,000   $2.05 
Exercised   (7,837  $2.20 
Forfeited and expired   (1,800,919  $7.12 
Outstanding at December 31, 2025   2,351,040   $5.59 
Vested options at December 31, 2025   1,588,969   $6.84 
 
The weighted average exercise price and remaining contractual life of options outstanding as of December 31, 2025 was $5.59 and 6.84 years, respectively. The total aggregate intrinsic value of the options outstanding as of December 31, 2025 was approximately $13,760.
 
The weighted average exercise price and remaining contractual life of exercisable options as of December 31, 2024 was $6.47 and 7.33 years, respectively. The total aggregate intrinsic value of the exercisable options as of December 31, 2024 was approximately $0.
 
Stock Compensation Expense
 
The weighted-average grant date fair value per share for the stock options granted was $1.41 and $1.99 for the years ended December 31, 2025 and 2024, respectively.
At December 31, 2025, the total unrecognized stock compensation expense related to unvested stock option awards and restricted stock awards and restricted stock units granted was $4,570,137, which the Company expects to recognize over a weighted-average period of approximately 1.7 years. Stock compensation expense for the years ended December 31, 2025 and 2024 was as follows:
 
         
           
 
 For the Year Ended December 31,  
     2025      2024  
Services  $140,867   $155,318 
Research and development   119,302    107,840 
Sales and marketing   365,097    275,679 
General and administrative   2,651,113    5,989,560 
Total  $3,276,379   $6,528,397 
 
Total intrinsic value of options exercised during the year ended December 31, 2025 was $2,351. The total fair value of restricted shares vested during the year ended December 31, 2025 was $910,550.
 
Total intrinsic value of options exercised during the year ended December 31, 2024 was $8,375. The total fair value of restricted shares vested during the year ended December 31, 2024 was $553,196.

Historical Timeline

Fiscal YearFiled
2025Mar 27, 2026Showing above
2024Apr 11, 2025
2022Mar 30, 2023
2021Mar 31, 2022

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.